HELMINTOX 250 mg, film-coated tablet 3 tablets
Active ingredients: Pyrantel pamoate, Pyrantel
Commercialized according to BDPM
Film-coated tablet3 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- HELMINTOX 250 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-Aluminium de 3 comprimé(s)
- Marketing authorisation holder
- INNOTECH INTERNATIONAL
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Mar 1989
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64047571CIP73305639CIP133400933056391Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| EMBONATE DE PYRANTELcomprimé | 721,00 mg · un comprimé | SA |
| PYRANTEL BASEcomprimé | 250 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.